CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Head & Neck Cancers
Immunotherapy in GU Cancers
Immunotherapy in Lung Cancer
Immunotherapy in Melanoma
Mantle Cell Lymphoma
Melanoma & Skin Cancer
Metastatic Castration-Resistant Prostate Cancer
Oncology Nursing News
Precision Medicine in Oncology
Soft Tissue Sarcoma
Special Reports in Personalized Cancer Care
Online Continuing Education Activities
SELECT A TOPIC
Business Management Videos
Further Sequencing in Squamous NSCLC
Panelists Mark A. Socinski, MD; Tracey L. Evans, MD; Jared Weiss, MD; and Edward S. Kim, MD, discuss their treatment considerations for patients with squamous non–small cell lung cancer who progress following first-line therapy and suggest when immunotherapy may or may not be appropriate compared to cytotoxic chemotherapy.
Update on Metastatic Squamous Non-Small Cell Lung Cancer
Dr. Oh on the Sequencing of New Therapies for Prostate Cancer
William K. Oh, MD, chief, Division of Hematology and Medical Oncology, professor of Medicine and Urology, Mount Sinai School of Medicine, discusses sequencing of new therapies for castration-resistant prostate cancer (CRPC).
Dr. Sanft on Sequencing of Treatments for HER2+ Breast Cancer
Tara Sanft, MD, assistant professor of Medicine, medical director of Adult Survivorship for Yale Cancer Center Survivorship Clinic, discusses sequencing of treatments for patients with HER2-positive breast cancer.
Dr. Usmani on Importance of CASTOR/POLLUX Trials in Myeloma
Saad Z. Usmani, MD, Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute/Carolinas HealthCare System, discusses the importance of the CASTOR and POLLUX trials for the treatment of patients with multiple myeloma.
Questions About Sequencing in BRAF-Mutant Melanoma
Panelists Jeffrey Weber, MD, PhD; Reinhard Dummer, MD; Axel Hauschild, MD; Caroline Robert, MD, PhD; and Dirk Schadendorf, MD, provide insight on sequencing in BRAF-mutant melanoma.
Global Perspectives on the Management of Malignant Melanoma
Dr. Berk on the Role of Hospitals Versus Independents
As insurers and the federal government look for ways to reduce costs in oncology, the division of care between large, academic institutions and smaller providers is undergoing a process of change, says Seth Berk, MD, chair of the Financial Audit Committee for Regional Cancer Care Associates (RCCA) and a Mount Holly, New Jersey, specialist in internal medicine, hematology and oncology.
Dr. Goldberg on PD-L1 as a Biomarker in Lung Cancer
Sarah B. Goldberg, MD, MPH, assistant professor of Medicine, Yale Cancer Center, discusses the use of PD-L1 as a biomarker in treating patients with lung cancer.
Dr. Saenger on the Importance of Biomarkers When Administering Immunotherapy
Yvonne Saenger, MD, director of Melanoma Immunotherapy at Columbia University Medical Center, discusses the importance of developing accurate biomarkers when it comes to administering immunotherapy.
Dr. Rimm on Biomarker Testing in Lung Cancer
David L. Rimm, MD, PhD, professor of pathology and of medicine, director of pathology tissue services, director of translational pathology, Yale Cancer Center, discusses various options for biomarker testing in lung cancer.
Final Thoughts on NSCLC
Panelists Benjamin P. Levy, MD; Chandra P. Belani, MD; Marina Garassino, MD; Ramaswamy Govindan, MD; Sarah B. Goldberg, MD, MPH; and Mark G. Kris, MD, outline their final thoughts on the current and future treatments of non-small cell lung cancer.
Latest Advances in Lung Adenocarcinoma
Next Page >>
NDA Withdrawn in Melanoma, Promising Phase III Results in Breast Cancer and Ovarian Cancer, and More
FDA Approves Niraparib for Ovarian Cancer
Expert Discusses CAR T-Cell Advances in ALL
Expert Discusses State of Bone-Targeted Therapy in Breast Cancer
Expert Provides Perspective on Immunotherapy Advances in Lung Cancer
Covering Every Angle of Oncology Practice. Click a cover below, to view more.
American Journal of Managed Care
Oncology Nursing News
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
Terms & Conditions
2 Clarke Drive
Cranbury, NJ 08512
Copyright OncLive 2006-2017
Intellisphere, LLC. All Rights Reserved.